Alembic
Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch
Some see this as an opportunity for Indian firms like Alembic, Aurobindo who make both the bulk drug and the formulation
 "Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch")
Alembic hits record high as board approves share buyback proposal
The stock hit a new high of Rs 72, up 8% on BSE after its board approved the proposal of buyback of equity shares of the company at price of Rs 80 per share through tender offer.
 "Alembic hits record high as board approves share buyback proposal")
Alembic gains on share buyback plan
The stock up 7% to Rs 63.20 on BSE in intra-day trade after the pharmaceutical company announced that its board will consider share buyback proposal on Tuesday, January 23, 2018.
 "Alembic gains on share buyback plan")
5 years on: Alembic m-cap up 4.5 times, pharma arm rises 13 times
Alembic has managed to revive from a loss of Rs 12 crore in FY12 to a profit of Rs 145 crore in FY17
 "5 years on: Alembic m-cap up 4.5 times, pharma arm rises 13 times")
Shareholder activism at Alembic Pharma: Issue unlikely to die in a hurry
Alembic's board rejected the request by Unifi Capital to appoint Murali Rajagopalachari as director
 "Shareholder activism at Alembic Pharma: Issue unlikely to die in a hurry")
Alembic to step up product filings for US
Alembic has increased the number of its projects for product development from 40 in 2013-14 to 200 now
 "Alembic to step up product filings for US")
Non-compliance with global norms a risk: Alembic
The company is debt-free and is positive that it will help it mobilise funds at low costs from external sources to implement its capital expenditure plans
